GVR Report cover Substance Abuse Treatment Market Size, Share & Trends Report

Substance Abuse Treatment Market Size, Share & Trends Analysis Report By Treatment (Tobacco/Nicotine and Vaping, Alcohol, Marijuana), End-Use (Hospitals, Clinics, Rehabilitations Centers), By Region, And Segment Forecasts, 2022 To 2030

  • Report ID: GVR453962
  • Number of Pages: 0
  • Format: Electronic (PDF)

The growth of substance abuse treatment market is attributed to the increasing demand for therapeutic options to meet the rising prevalence rate of addicted population. With the increasing addiction population, there is an increasing interest of market players in development of novel treatments to meet the surge in demand for substance abuse therapeutics. Moreover, increasing drug awareness campaigns and rehabilitation programs are expected to further propel the demand for effective therapeutic alternatives.

Increasing global initiatives to create awareness amongst the addicted population is one of the major factors driving market growth. For instance, the WHO celebrates World No Tobacco Day on May 31 each year globally. In addition, in June 2021, DC Health launched public education campaign MyRecoveryDC, for helping addicted individuals to help them provide access to treatment and recovery services addicted to alcohol, drugs, and alcohol. Moreover, in October 2022, Qnovia raised USD 17 million for fighting against nicotine addiction.

Substance abuse kills around 11.8 million people worldwide. The major proportion of the population is addicted to alcohol and tobacco which makes it a major public health problem. There are various steps have been taken for encouraging several awareness-raising activities with the help of contributions from individuals, private sector organizations, and non-profit organizations. These global steps are helping individuals to opt for de-addiction therapies thereby driving market growth. 

North America dominated the overall market in 2022 which can be attributed to the growing population exposed to addiction, legalization of marijuana in various states, well-structured reimbursement policies, and the developed healthcare sector with effective therapeutics for drug addiction, which is supporting the growth of the market in this region. It is estimated that around 21 million people in the region have at least 1 addiction, which usually starts with alcohol which is one of the most widely abused substances eventually leading to the abuse of opioids, marijuana, nicotine, heroin, and cocaine. These substances generally affect the brain’s normal function and lead to harmful consequences on a person’s health. However, to tackle and provide treatment for such additions, the region has a presence of organizations such as the American Society of Addiction Medicine, which is home to addiction medicine specialists and physicians.

Substance Abuse Treatment Market Segmentation

Attribute

Details

Treatment

Tobacco/Nicotine and Vaping, Alcohol, Marijuana, Synthetic Cannabinoids, Prescription and Over-the-Counter Medications, and Others

End-Use

Hospitals, Clinics, Rehabilitation Centers, Others

Distribution Channel

Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

 

Major companies operating in the market include Abbott; Teva Pharmaceutical Industries Ltd., GSK plc.; Eli Lilly and Company; Cipla Inc.; Novartis AG; AstraZeneca, Alkermes, and Mallinckrodt. These players are focusing on product launches and geographical expansion to maintain their presence in the market. For instance, in November 2022, Indivior PLC entered into an agreement with Opiant Pharmaceuticals, Inc., this initiative is expected to extend and strengthen Indivior's position in the addiction treatment market.

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon